FI960392A0 - Immunoassay for the detection of collagen or collagen fragments - Google Patents

Immunoassay for the detection of collagen or collagen fragments

Info

Publication number
FI960392A0
FI960392A0 FI960392A FI960392A FI960392A0 FI 960392 A0 FI960392 A0 FI 960392A0 FI 960392 A FI960392 A FI 960392A FI 960392 A FI960392 A FI 960392A FI 960392 A0 FI960392 A0 FI 960392A0
Authority
FI
Finland
Prior art keywords
collagen
immunoassay
fragments
detection
sample
Prior art date
Application number
FI960392A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI960392A (en
Inventor
Werner Naser
Erasmus Huber
Christoph Seidel
Ulrich Essig
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP1993/002010 external-priority patent/WO1994003813A1/en
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of FI960392A publication Critical patent/FI960392A/en
Publication of FI960392A0 publication Critical patent/FI960392A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)

Abstract

An immunoassay is disclosed for detecting collagen or collagen fragments in a sample by using an antibody that recognises a synthetic linear peptide corresponding to a sequence of non-helical C or N terminal area of collagen, said sample being preferably denatured.
FI960392A 1993-07-28 1996-01-29 Immunoassay for the detection of collagen or collagen fragments FI960392A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/EP1993/002010 WO1994003813A1 (en) 1992-07-29 1993-07-28 Immunoassay for detecting collagen or collagen fragments
PCT/EP1994/000164 WO1995004282A1 (en) 1993-07-28 1994-01-21 Immunoassay for detecting collagen or collagen fragments

Publications (2)

Publication Number Publication Date
FI960392A FI960392A (en) 1996-01-29
FI960392A0 true FI960392A0 (en) 1996-01-29

Family

ID=8165750

Family Applications (1)

Application Number Title Priority Date Filing Date
FI960392A FI960392A0 (en) 1993-07-28 1996-01-29 Immunoassay for the detection of collagen or collagen fragments

Country Status (9)

Country Link
EP (1) EP0711415B1 (en)
JP (1) JP2703116B2 (en)
AT (1) ATE168779T1 (en)
CA (1) CA2167496A1 (en)
DE (1) DE59406512D1 (en)
DK (1) DK0711415T3 (en)
ES (1) ES2122231T3 (en)
FI (1) FI960392A0 (en)
WO (1) WO1995004282A1 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6110689A (en) 1994-01-21 2000-08-29 Osteometer A/S Method of assaying collagen fragments in body fluids, a test kit and means for carrying out the method and use of the method to diagnose the presence of disorders associated with the metabolism of collagen
GB9506050D0 (en) 1995-03-24 1995-05-10 Osteometer A S Assaying collagen fragments in body fluids
JPH10507266A (en) 1994-10-17 1998-07-14 オステオミーター・ビオ・テク・エー／エス Evaluation of collagen fragmentation pattern in body fluids and diagnosis of diseases related to collagen metabolism
US5750647A (en) * 1995-05-19 1998-05-12 Washington Research Foundation Synthetic peptide analogs of NTx
US6107047A (en) * 1996-03-21 2000-08-22 Osteometer Biotech A/S Assaying protein fragments in body fluids
GB9617616D0 (en) 1996-08-22 1996-10-02 Osteometer Biotech As Assaying protein fragments in body fluids
WO1998026286A2 (en) 1996-12-09 1998-06-18 Osteometer Biotech A/S Sandwich assays for collagen type i fragments
US6117646A (en) * 1997-09-22 2000-09-12 Osteometer Biotech A/S Assaying protein fragments in body fluids
US6602980B1 (en) 1998-06-19 2003-08-05 Washington Research Foundation Collagen type III synthetic peptides for collagen resorption assays
US6348320B1 (en) 1998-06-19 2002-02-19 Washington Research Foundation Cartilage resorption assays measuring type II collagen fragments
ATE302949T1 (en) 1998-06-19 2005-09-15 Washington Res Found CARTILAGE RESORPTION ASSAY
US6916903B2 (en) 1998-06-19 2005-07-12 Washington Research Foundation Collagen type III synthetic peptides for collagen resorption assays
WO2000040597A1 (en) 1999-01-06 2000-07-13 University Of Southern California Method and composition for angiogenesis inhibition
CN1379685A (en) 1999-07-13 2002-11-13 南加利福尼亚大学 Novel method and composition for inhibition of angiogenesis using antagonists based on MMP-9 and beta integrins
US7365167B2 (en) 2001-11-26 2008-04-29 Cell Matrix, Inc. Humanized collagen antibodies and related methods
US7390885B2 (en) 2001-11-26 2008-06-24 Cell Matrix, Inc. Humanized collagen antibodies and related methods
US7488792B2 (en) 2002-08-28 2009-02-10 Burnham Institute For Medical Research Collagen-binding molecules that selectively home to tumor vasculature and methods of using same
JP2004108914A (en) * 2002-09-18 2004-04-08 Kudo Norio Method for measuring collagen
US7781171B2 (en) 2003-10-15 2010-08-24 Daiichi Pure Chemicals Co., Ltd. Mehod of pretreating sample and immunological assay method using the same
CN1864067B (en) * 2003-10-15 2011-07-06 积水医疗株式会社 Method of pretreating sample and immunological assay method using the same
CN117561445A (en) 2021-03-24 2024-02-13 积水医疗株式会社 Immunological analysis method of C-terminal peptide of type I collagen
WO2024034580A1 (en) * 2022-08-08 2024-02-15 株式会社先端生命科学研究所 Method for detecting ceacam1

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3479158D1 (en) * 1983-03-04 1989-08-31 Noctech Ltd Diagnostic agent, a process for its preparation and its use in diagnostic methods
CA1339952C (en) * 1984-10-29 1998-07-14 William J. Knowles Immunoassays for denatured protein analytes, particularly hb alc, and monoclonal antibodies thereto
DE3714634A1 (en) * 1987-05-02 1988-11-17 Hoechst Ag METHOD FOR SELECTIVE IMMUNOLOGICAL DETERMINATION OF INTACT PROCOLLAGEN PEPTIDE (TYPE III) AND PROCOLLAGEN (TYPE III) IN BODY LIQUIDS AND MEANS TO IMPLEMENT IT
ATE115963T1 (en) * 1988-04-27 1995-01-15 Hoechst Ag MONOCLONAL ANTIBODIES FOR SELECTIVE IMMUNOLOGICAL DETERMINATION OF INTACT PROCOLLAGEN PEPTIDE (TYPE III) AND PROCOLLAGEN (TYPE III) IN BODY FLUID.
WO1990008195A1 (en) * 1989-01-13 1990-07-26 President And Fellows Of Harvard College Monoclonal antibody to human type ix collagen
US5081031A (en) * 1989-12-14 1992-01-14 Regents Of The University Of Minnesota Synthetic polypeptide with type iv collagen activity
GB9014220D0 (en) * 1990-06-26 1990-08-15 Farmos Yhtymy Oy Method for the immunlolgical determinition of the carboxyterminal propeptide of type i procollagen
GB9105893D0 (en) * 1991-03-20 1991-05-08 Orion Yhtymae Oy Bone resorption assay based on a peptide liberated during collagen degradation
ATE161543T1 (en) * 1992-01-31 1998-01-15 David Jeston Baylink AMINOTERMINAL PROCOLLAGEN 1(I) PEPTIDES
DE4225038C2 (en) * 1992-07-29 1995-11-30 Boehringer Mannheim Gmbh Production and use of antibodies against collagen

Also Published As

Publication number Publication date
FI960392A (en) 1996-01-29
JPH08509294A (en) 1996-10-01
EP0711415A1 (en) 1996-05-15
DE59406512D1 (en) 1998-08-27
WO1995004282A1 (en) 1995-02-09
EP0711415B1 (en) 1998-07-22
DK0711415T3 (en) 1999-04-26
CA2167496A1 (en) 1995-02-09
ATE168779T1 (en) 1998-08-15
JP2703116B2 (en) 1998-01-26
ES2122231T3 (en) 1998-12-16

Similar Documents

Publication Publication Date Title
FI960392A0 (en) Immunoassay for the detection of collagen or collagen fragments
DE69228701D1 (en) Fragments of prion proteins.
LU91087I2 (en) Advate (Octocog alfa) subtotes its forms protected by the basic patent.
DK532284A (en) PROCEDURE FOR DETERMINING ANTI-ANTI-ACTIVE AMINO ACID SEQUENCES
DE59309458D1 (en) Synthetic peptides, antibodies against them and their use
EP2048505A3 (en) Method for early recognition of the seroconversion of an antibody to hepatitis C
ATE225512T1 (en) SEPARATION PROCESS
DE68929334D1 (en) Method for assaying endotoxin concentration
DE3481861D1 (en) ANTIGING RELATED TO EARLY DETERMINATION OF PREGNANCY IN MAMMALS.
ATE191792T1 (en) METHOD FOR DETECTING HEPATITIS C
DK0457804T3 (en) M-CSF monoclonal antibodies that recognize a neutralizing, conformational epitope
ATE120492T1 (en) FV ANTIBODY FRAGMENT PRODUCTION.
ATE133993T1 (en) PROTEIN ANTICANCER
BR9712585A (en) Process of highlighting live microbiological contaminants in a product sample for food use
ES2113356T3 (en) PEPTIDES WITH AN CHARACTERISTIC ANTIGENIC DETERMINANT FOR ALPHA-1-MICRO-GLOBULIN.
ES2115750T3 (en) UNION PROTEIN CAPTURE TEST.
ATE228847T1 (en) INHIBITORS OF CATALYTIC ANTIBODIES
DE59709495D1 (en) Antibodies and immunoassay for the detection of MIA
DE3485219D1 (en) TGF POLYPEPTIDES, DERIVATIVE ANTIGEN OLIGOPEPTIDES, ANTIBODIES OBTAINED THEREOF.
DE69028561D1 (en) Immunoassay for the detection of antibodies against HIV
DE69233666D1 (en) Branched peptides for the detection of antibodies
KR900016464A (en) Monoclonal Antibodies Recognizing the C-terminus of ANP
DE69011879D1 (en) Immune test procedure for cellular protein.
KR890009417A (en) Method for producing monoclonal antibody and method of using the same
NO982227D0 (en) Urogenital carcinoma-TPL complex peptides and antibodies thereof

Legal Events

Date Code Title Description
HC Name/ company changed in application

Owner name: ROCHE DIAGNOSTICS GMBH